Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Variables associated with patient activation in persons with multiple sclerosis.
Subcortical atrophy and cognition: Sex effects in multiple sclerosis.
Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders.
Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System.
Management of multiple sclerosis: An overview.
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.
Accentia Biopharmaceuticals Announces that Revimmune Autoimmune Disease Therapy is Featured in Peer-review Journal
Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
Assessing walking disability in multiple sclerosis.
Studies of EN-1639A (naltrexone): a new narcotic antagonist.
Biomarkers in multiple sclerosis.
New TYSABRI® data show earlier treatment and longer-term use result in significant reductions in MS disease activity
Genetic burden of common variants in progressive and bout-onset multiple sclerosis.
Distraction adds to the cognitive burden in multiple sclerosis.
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
Does fatigue occur in MS patients without disability? Suggested running head: Fatigue and disability in MS.
Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis.
Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?
Evaluating the potential benefit of interferon treatment in multiple sclerosis.
Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles.
The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
Association of SNPs rs6498169 and rs10984447 with multiple sclerosis in Saudi Patients: a model of the usefulness of familial aggregates in identifying genetic linkage in a multifactorial disease.
Pages
« first
‹ previous
…
179
180
181
182
183
184
185
186
187
…
next ›
last »